Zeynep Busra Bolat

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 05, 2025
All-trans retinoic acid enhances anti-proliferative effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in triple negative breast cancer.

Suranur Ayvaz, Zeynep Busra Bolat

|Oct 30, 2024
Delivery of BikDD proapoptotic gene in Peptide-18-targeted Poly(2-oxazoline)-DOPE nanoliposomes for breast cancer models.

Zeynep Büşra Bolat, Ayça Ece Nezir, Ongun Mehmet Saka

|Jul 25, 2024
PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted BikDDA delivery to prostate cancer.

Ayca Ece Nezir, Zeynep Büşra Bolat, Ongun Mehmet Saka

|Dec 10, 2023
Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells.

Fadime Çetin, Sifa Kosba, Hüseyin Abdik

|Jun 15, 2023
Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers.

Ayca Ece Nezir, Zeynep Busra Bolat, Naile Ozturk

|Nov 16, 2020
The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(ε-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to Prostate Cancer.

Polen Kocak, Umut Can Oz, Zeynep Busra Bolat

Pageof 1

Frequent Collaborators

4 joint publications

Umut Ugur Ozkose

4 joint publications

Sevgi Gulyuz

4 joint publications

Ozgur Yilmaz

4 joint publications

Asuman Bozkır